These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3374302)

  • 1. [Determination of the limits of the norm for concentrations of physiologically active substances in the blood during population radioimmunologic studies].
    Bolotin AS
    Med Radiol (Mosk); 1988 May; 33(5):45-8. PubMed ID: 3374302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonuniform dose distributions in normal body organs and tissues in the radiotherapy of malignant tumors].
    Klepper LIa
    Med Tekh; 1999; (5):6-10. PubMed ID: 10560087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific nature of the software used to construct simulations: physiologically-based toxicokinetic models].
    Jałowiecki P; Kostrzewski P
    Med Pr; 2001; 52(5):361-8. PubMed ID: 11828851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An example of model structure differences using sensitivity analyses in physiologically based pharmacokinetic models of trichloroethylene in humans.
    Yokley KA; Evans MV
    Bull Math Biol; 2007 Nov; 69(8):2591-625. PubMed ID: 17896160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model for the cell age-dependent decline of creatine in human cell cells.
    Holzhütter HG; Syllm-Rapoport I; Daniel A
    Biomed Biochim Acta; 1984; 43(2):153-8. PubMed ID: 6732753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spirographic reference values. Mathematical models and practical use (author's transl)].
    Drouet D; Kauffmann F; Brille D; Lellouch J
    Bull Eur Physiopathol Respir; 1980; 16(6):745-67. PubMed ID: 7448465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations.
    Rinaldi S; Geay A; Déchaud H; Biessy C; Zeleniuch-Jacquotte A; Akhmedkhanov A; Shore RE; Riboli E; Toniolo P; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1065-71. PubMed ID: 12376508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioimmunoassay and its problems: quality, sources of error and quality control of in vitro procedures for thyroid diagnosis].
    Meinhold H
    Nuklearmedizin; 1983 Aug; 22(4):196-203. PubMed ID: 6634418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four mathematical models for the calculation of radioimmunoassay data of LH, FSH, and GH.
    Geier T; Rohde W
    Endokrinologie; 1981 Dec; 78(2-3):269-80. PubMed ID: 6800778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunologic studies of glomerulonephritis in children].
    Ametov AS; Gavriushova LP; Shashinka M; Mumladze EB; Tvorogova TM
    Med Radiol (Mosk); 1985 Dec; 30(12):40-3. PubMed ID: 4079691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
    Allen BC; Hack CE; Clewell HJ
    Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems analysis of functional magnetic resonance imaging data using a physiologic model of venous oxygenation.
    Woo JH; Hathout GM
    J Cereb Blood Flow Metab; 2001 May; 21(5):517-28. PubMed ID: 11333362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of radiological models and radiological invariants (constants). (Part 3: synthesis of population-phenomenological models and Klepper model)].
    Klepper LIa
    Med Tekh; 2006; (3):22-6. PubMed ID: 16875141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment.
    Clark LH; Setzer RW; Barton HA
    Risk Anal; 2004 Dec; 24(6):1697-717. PubMed ID: 15660623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general mathematical framework to model generation structure in a population of asynchronously dividing cells.
    León K; Faro J; Carneiro J
    J Theor Biol; 2004 Aug; 229(4):455-76. PubMed ID: 15246784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confidence bands for the growth of head circumference in achondroplastic children during the first year of life.
    Dawson DV; Todorov AB; Elston RC
    Am J Med Genet; 1980; 7(4):529-36. PubMed ID: 7211962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.
    Mörk AK; Jonsson F; Johanson G
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):423-32. PubMed ID: 19660484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
    Pelekis M; Gephart LA; Lerman SE
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a portable clinical analyzer in a veterinary hospital setting.
    Grosenbaugh DA; Gadawski JE; Muir WW
    J Am Vet Med Assoc; 1998 Sep; 213(5):691-4. PubMed ID: 9731265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.